Benzinga's Top Pre-Market NASDAQ Gainers (SNTS, MNKD, LOGI, DRYS)

Santarus Inc SNTS rose 7.26% to $3.40 in the pre-market session. SNTS and Pharming Group NV PHARM submitted a Biologics License Application (BLA) for RHUCIN to the US Food and Drug Administration (FDA). MannKind Corporation MNKD added 5.40% to $8.40 in pre-market trading. MNKD reported that US Food and Drug Administration (FDA) require additional 4 weeks for reviewing MNKD's inhaled insulin Afrezza. Logitech International SA LOGI moved up 2.85% to $19.11 in pre-market trading. LOGI had $307.68 million in total cash and no debt for the recent quarter. DryShips Inc DRYS gained 1.08% to $5.61 in the pre-market session. DRYS agreed to purchase 12 tankers for $770 million. Read more from Benzinga's Markets.